Noticias
Anuncios, alianzas e hitos de la empresa.
Noticias de la empresa
(7)Synthgene Bio in cooperation with BIORON and BION2 signs Distribution Agreement East Europe
The partnership between Synthgene Bio, BIORON, and Bion2 represents a major step toward global expansion, enhancing access to key resources for mRNA and oligo research and manufacturing in Eastern Europe. FOR IMMEDIATE RELEASE Gaithersburg, MD, USA and Römerberg, Germany (February 20, 2025) — Areterna LLC, a subsidiary of Synthgene Bio and pioneer with innovative Nucleic Acid
Leer másAreterna and Biomay Announce Strategic Partnership to Jointly Serve mRNA CDMO Customers in Europe and North America
Collaboration expands Areterna’s reach in Europe and strengthens Biomay’s mRNA CDMO offerings. Gaithersburg, MD and Vienna, Austria (September 18, 2024) — Areterna LLC, a company with a mission to democratize mRNA products by supplying low-cost GMP raw materials, today announced it has entered a strategic partnership with Biomay, a seasoned CDMO that offers GMP manufacturing
Leer másGMP Raw Materials Used in Clinical Trials
Synthgene Biotechnology, Areterna’s parent company, has been a leading producer of GMP-grade cap analogs, NTPs, and modified NTPs for several years, establishing a strong reputation for quality and reliability in the industry. Our raw materials play a crucial role in over 25 clinical mRNA programs, addressing a diverse range of medical needs. These programs include
Leer másSynthgene / Areterna now has DMF for CAP5 at FDA
Recently, Synthgene Biotech (hereinafter referred to as “Synthgene”), Areterna’s parent company, received a confirmation letter from the United States Food and Drug Administration (FDA) for one of our core mRNA raw material products – CAP5 – which have been listed on the FDA website. Cap5 is a novel cap analog developed by Synthgene and shows
Leer másAreterna Announces Veterinary mRNA Vaccine Development Service
FOR IMMEDIATE RELEASE Gaithersburg, MD (July 2nd, 2024) — Areterna LLC, a company with a mission to democratize mRNA vaccine by supplying low-cost GMP raw materials, today announced plans to offer veterinary mRNA vaccine development service to its customers in the US and Europe. The success of COVID vaccines has validated mRNA as a therapeutic
Leer másAreterna LLC, a Synthgene Company, and BIORON GmbH Sign Global Distribution Agreement
FOR IMMEDIATE RELEASE Areterna LLC, a subsidiary of Synthgene Biotech renowned for providing top-tier raw materials and services catering to mRNA and oligonucleotide therapeutics, has signed a global distribution agreement with BIORON GmbH, a premium manufacturer and worldwide-acting distributor of molecular biological and diagnostic products. Through this distribution relationship, customers in Europe will have easier
Leer másAreterna LLC, a Synthgene Company, and Medsol Corporation Sign Global Distribution Agreement
FOR IMMEDIATE RELEASE Areterna LLC, a subsidiary of Synthgene Biotech, established for the purpose of providing raw materials and services tailored to mRNA and oligonucleotide therapeutics, has entered into a global distribution agreement with Medsol Corporation, a leading distributor of molecular biological and diagnostic products headquartered in Egypt. This partnership aims to enhance accessibility to
Leer más